Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 555 JPY 4.59% Market Closed
Market Cap: 128B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

57.2B
+2%
Revenue
Growth Rates:
1 Year
+11%
3 Years
+32%
5 Years
+9%
7 Years
-7%
10 Years
+1%
6.7B
-3%
Operating Income
Growth Rates:
1 Year
+53%
3 Years
+76%
5 Years
+113%
7 Years
+68%
10 Years
+53%
5.3B
-0.6%
Net Income
Growth Rates:
1 Year
+65%
3 Years
+79%
5 Years
-80%
7 Years
+69%
10 Years
+77%

Earnings Waterfall
Torii Pharmaceutical Co Ltd

Revenue
57.2B JPY
Cost of Revenue
-31.8B JPY
Gross Profit
25.5B JPY
Operating Expenses
-18.8B JPY
Operating Income
6.7B JPY
Other Expenses
-1.4B JPY
Net Income
5.3B JPY

Income Statement
Torii Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
56 517
N/A
57 107
+1%
43 504
-24%
56 802
+31%
60 583
+7%
61 489
+1%
62 378
+1%
62 820
+1%
61 957
-1%
61 305
-1%
60 206
-2%
60 074
0%
61 283
+2%
62 164
+1%
64 135
+3%
64 457
+1%
64 596
+0%
63 952
-1%
62 551
-2%
57 782
-8%
52 684
-9%
48 328
-8%
42 998
-11%
43 408
+1%
42 171
-3%
41 850
-1%
41 700
0%
42 028
+1%
43 398
+3%
44 965
+4%
46 987
+4%
48 048
+2%
48 534
+1%
48 865
+1%
48 896
+0%
49 747
+2%
51 493
+4%
52 713
+2%
54 638
+4%
56 278
+3%
57 248
+2%
Gross Profit
Cost of Revenue
(25 810)
(26 527)
(20 587)
(26 985)
(29 044)
(30 257)
(30 814)
(30 891)
(30 810)
(30 567)
(30 287)
(30 614)
(30 905)
(31 032)
(31 293)
(31 445)
(32 356)
(32 238)
(31 844)
(29 282)
(25 792)
(23 142)
(20 702)
(20 759)
(20 395)
(20 405)
(19 962)
(20 308)
(20 977)
(21 604)
(22 649)
(23 527)
(24 206)
(24 853)
(25 516)
(26 131)
(27 237)
(28 220)
(29 847)
(31 046)
(31 778)
Gross Profit
30 707
N/A
30 580
0%
22 917
-25%
29 817
+30%
31 539
+6%
31 232
-1%
31 564
+1%
31 929
+1%
31 147
-2%
30 738
-1%
29 919
-3%
29 460
-2%
30 378
+3%
31 132
+2%
32 842
+5%
33 012
+1%
32 240
-2%
31 714
-2%
30 707
-3%
28 500
-7%
26 892
-6%
25 186
-6%
22 296
-11%
22 649
+2%
21 776
-4%
21 445
-2%
21 738
+1%
21 720
0%
22 421
+3%
23 361
+4%
24 338
+4%
24 521
+1%
24 328
-1%
24 012
-1%
23 380
-3%
23 616
+1%
24 256
+3%
24 493
+1%
24 791
+1%
25 232
+2%
25 470
+1%
Operating Income
Operating Expenses
(26 356)
(25 875)
(18 885)
(25 040)
(25 731)
(26 025)
(26 645)
(26 571)
(26 472)
(26 739)
(26 100)
(26 292)
(26 405)
(26 227)
(26 561)
(26 495)
(26 221)
(26 049)
(25 756)
(25 027)
(23 760)
(22 617)
(20 866)
(19 258)
(17 898)
(17 124)
(17 000)
(17 545)
(18 633)
(19 023)
(19 682)
(19 262)
(18 778)
(18 443)
(17 840)
(19 805)
(19 888)
(19 808)
(19 756)
(18 377)
(18 804)
Selling, General & Administrative
(20 206)
(20 210)
(15 239)
(20 520)
(21 122)
(21 212)
(21 015)
(21 410)
(21 548)
(21 593)
(21 025)
(21 528)
(21 565)
(21 632)
(21 524)
(22 021)
(21 780)
(21 855)
(21 267)
(20 918)
(19 841)
(18 990)
(17 599)
(17 229)
(16 494)
(16 296)
(16 165)
(16 897)
(17 985)
(18 372)
(18 591)
(18 363)
(17 694)
(17 034)
(15 944)
(16 262)
(16 396)
(16 425)
(16 047)
(16 410)
(16 363)
Research & Development
(6 148)
(5 664)
(3 400)
(4 519)
(4 609)
(4 813)
(5 237)
(5 160)
(4 925)
(5 147)
(4 654)
(4 764)
(4 838)
(4 593)
(4 608)
(4 472)
(4 440)
(4 193)
(4 138)
(4 108)
(3 918)
(3 625)
(2 956)
(2 027)
(1 403)
(825)
(596)
(647)
(646)
(650)
(832)
(900)
(1 084)
(1 410)
(1 661)
(3 542)
(3 491)
(3 383)
(3 490)
(1 965)
(2 440)
Depreciation & Amortization
0
0
(246)
0
0
0
(393)
0
0
0
(420)
0
0
0
(427)
0
0
0
(350)
0
0
0
(309)
0
0
0
(238)
0
0
0
(259)
0
0
0
(234)
0
0
0
(218)
0
0
Other Operating Expenses
(2)
(1)
0
(1)
0
0
0
(1)
1
1
(1)
0
(2)
(2)
(2)
(2)
0
(1)
(1)
0
0
0
(2)
(2)
(1)
(3)
(1)
(1)
(2)
(1)
0
0
0
0
(1)
(1)
(1)
0
(1)
(2)
0
Operating Income
4 351
N/A
4 705
+8%
4 032
-14%
4 777
+18%
5 808
+22%
5 207
-10%
4 919
-6%
5 358
+9%
4 675
-13%
3 999
-14%
3 819
-5%
3 168
-17%
3 973
+25%
4 905
+23%
6 281
+28%
6 517
+4%
6 019
-8%
5 665
-6%
4 951
-13%
3 473
-30%
3 132
-10%
2 569
-18%
1 430
-44%
3 391
+137%
3 878
+14%
4 321
+11%
4 738
+10%
4 175
-12%
3 788
-9%
4 338
+15%
4 656
+7%
5 259
+13%
5 550
+6%
5 569
+0%
5 540
-1%
3 811
-31%
4 368
+15%
4 685
+7%
5 035
+7%
6 855
+36%
6 666
-3%
Pre-Tax Income
Interest Income Expense
28
27
89
111
99
154
165
102
117
64
106
61
43
43
61
55
67
53
105
103
132
184
215
112
148
117
198
17
(23)
(19)
121
(24)
84
112
305
213
49
55
575
334
394
Non-Reccuring Items
6
(349)
(361)
(361)
(399)
(94)
(196)
110
150
200
(29)
(31)
(33)
(32)
(29)
(13)
(38)
(33)
(2 049)
38 554
34 366
34 307
36 008
(4 603)
(1 153)
(1 082)
(746)
(738)
3
(13)
(40)
(40)
(15)
(15)
(2)
(3)
(4)
(4)
(37)
(42)
(43)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
320
0
0
0
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
96
90
21
47
57
66
50
104
91
118
74
188
191
158
60
64
65
83
23
58
57
33
47
161
165
167
35
112
115
115
30
169
17
15
(121)
50
194
193
20
11
12
Pre-Tax Income
4 481
N/A
4 473
0%
3 781
-15%
4 574
+21%
5 565
+22%
5 333
-4%
5 258
-1%
5 674
+8%
5 033
-11%
4 381
-13%
4 056
-7%
3 386
-17%
4 174
+23%
5 074
+22%
6 373
+26%
6 623
+4%
6 113
-8%
5 768
-6%
3 030
-47%
42 188
+1 292%
37 687
-11%
37 093
-2%
37 700
+2%
(939)
N/A
3 038
N/A
3 523
+16%
4 225
+20%
3 566
-16%
3 883
+9%
4 421
+14%
4 767
+8%
5 364
+13%
5 636
+5%
5 681
+1%
5 722
+1%
4 071
-29%
4 607
+13%
4 929
+7%
5 593
+13%
7 158
+28%
7 029
-2%
Net Income
Tax Provision
(1 508)
(1 443)
(1 361)
(1 621)
(1 948)
(1 823)
(1 730)
(1 875)
(1 655)
(1 429)
(1 216)
(961)
(1 056)
(1 217)
(1 655)
(1 725)
(1 607)
(1 574)
(1 865)
(13 069)
(11 876)
(11 709)
(10 333)
646
(65)
(114)
(729)
(497)
(944)
(1 196)
(1 392)
(1 543)
(1 660)
(1 688)
(1 778)
(1 298)
(1 421)
(1 473)
(1 473)
(1 870)
(1 775)
Income from Continuing Operations
2 973
3 030
2 420
2 953
3 617
3 510
3 528
3 799
3 378
2 952
2 840
2 425
3 118
3 857
4 718
4 898
4 506
4 194
1 165
29 119
25 811
25 384
27 367
(293)
2 973
3 409
3 496
3 069
2 939
3 225
3 375
3 821
3 976
3 993
3 944
2 773
3 186
3 456
4 120
5 288
5 254
Net Income (Common)
2 972
N/A
3 031
+2%
2 419
-20%
2 951
+22%
3 616
+23%
3 509
-3%
3 527
+1%
3 798
+8%
3 378
-11%
2 951
-13%
2 839
-4%
2 424
-15%
3 117
+29%
3 855
+24%
4 718
+22%
4 899
+4%
4 505
-8%
4 195
-7%
1 164
-72%
29 117
+2 401%
25 810
-11%
25 382
-2%
27 367
+8%
(293)
N/A
2 973
N/A
3 409
+15%
3 495
+3%
3 069
-12%
2 939
-4%
3 225
+10%
3 374
+5%
3 820
+13%
3 975
+4%
3 992
+0%
3 944
-1%
2 774
-30%
3 185
+15%
3 456
+9%
4 119
+19%
5 285
+28%
5 254
-1%
EPS (Diluted)
106.14
N/A
108.25
+2%
86.39
-20%
105.39
+22%
129.14
+23%
125.32
-3%
124.63
-1%
135.64
+9%
120.64
-11%
105.39
-13%
100.38
-5%
86.57
-14%
111.32
+29%
137.67
+24%
162.8
+18%
174.96
+7%
160.89
-8%
149.82
-7%
41.49
-72%
1 037.64
+2 401%
919.51
-11%
904.06
-2%
974.99
+8%
-10.45
N/A
105.86
N/A
121.41
+15%
124.46
+3%
109.28
-12%
104.64
-4%
114.82
+10%
120.11
+5%
135.98
+13%
141.49
+4%
142.06
+0%
140.38
-1%
98.73
-30%
113.34
+15%
122.98
+9%
146.57
+19%
188.05
+28%
186.93
-1%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 198,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.